Want to join the conversation?
$TWTR expects 4Q15 revenue of $695-710MM and adjusted EBITDA of $155-175MM. GAAP expenses are projected to include vast majority of $5-15MM of restructuring charges expected from corporate restructuring activities. These charges are expected to be $10-20MM in cash expenditure. CapEx are projected to be no more than $110MM.
Biodefense therapeutics firm $PIP announced an all-stock merger with biotech Altimmune. The respective boards of the two companies unanimously approved the merger.
$YHOO is reporting today after market close. Nobody cares about this stock.